Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review

被引：1
|
作者：
Wang, Nan [1 ]
Que, Hanyun [1 ]
Luo, Qiulin [1 ]
Zheng, Wenxin [1 ]
Li, Hong [1 ]
Wang, Qin [1 ,2 ]
Gu, Jian [1 ]
机构：
[1] Southwest Minzu Univ, Coll Pharm, Chengdu, Peoples R China
[2] Sichuan Univ, Coll Biomass Sci & Engn, BMI Ctr Biomass Mat & Nanointerfaces, Chengdu 610065, Peoples R China
来源：
FRONTIERS IN MEDICINE | 2024年 / 11卷
关键词：
ferroptosis; nonalcoholic fatty liver disease; traditional Chinese medicine; nonalcoholic steatohepatitis; mechanisms; EPIGALLOCATECHIN GALLATE; CELL-DEATH; QUERCETIN; RUTIN; STEATOHEPATITIS; NAFLD; FORM;
D O I：
10.3389/fmed.2024.1356225
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)), and lobular inflammation and hepatocyte damage (which characterize nonalcoholic steatohepatitis (NASH) are found in most patients). A subset of patients will gradually develop liver fibrosis, cirrhosis, and eventually hepatocellular carcinoma, which is a deadly disease that threatens human life worldwide. Ferroptosis, a novel nonapoptotic form of programmed cell death (PCD) characterized by iron-dependent accumulation of reactive oxygen radicals and lipid peroxides, is closely related to NAFLD. Traditional Chinese medicine (TCM) has unique advantages in the prevention and treatment of NAFLD due to its multicomponent, multipathway and multitarget characteristics. In this review, we discuss the effect of TCM on NAFLD by regulating ferroptosis, in order to provide reference for the further development and application of therapeutic drugs to treat NAFLD.
引用
收藏
页数：12
相关论文
共 50 条
  • [31] Therapeutic options in nonalcoholic fatty liver disease
    Jeffrey L. Tokar
    Carl L. Berg
    Current Treatment Options in Gastroenterology, 2002, 5 (6) : 425 - 436
  • [32] Mechanisms Underlying Therapeutic Effects Of Traditional Chinese Medicine On Gastric Cancer
    Yang, Linjun
    Zhao, Liqian
    Zeng, Tianni
    Chen, Hong
    Shao, Jingjing
    Yang, Song
    Tao, Zheying
    Yang, Jingqin
    Chen, Tongke
    Lin, Xiaokun
    Chen, Xiwen
    Tang, Mosheng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8407 - 8418
  • [33] Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease
    Zhao, Shengnan
    Guo, Yan
    Yin, Xunzhe
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12):
  • [34] The therapeutic effects of polysaccharide sulfate on nonalcoholic fatty liver disease in rats
    Zhao, Jin-Sheng
    Duan, Ya-Le
    Li, Zhi
    Hao, Li-Ying
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 156P - 156P
  • [35] Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease
    Liu, Wensheng
    Baker, Susan S.
    Baker, Robert D.
    Zhu, Lixin
    CURRENT DRUG TARGETS, 2015, 16 (12) : 1301 - 1314
  • [36] Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
    Haas, Joel T.
    Francque, Sven
    Staels, Bart
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 78, 2016, 78 : 181 - 205
  • [37] Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
    Arun J Sanyal
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 46 - 53
  • [38] Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
    Jou, Janice
    Choi, Steve S.
    Diehl, Anna Mae
    SEMINARS IN LIVER DISEASE, 2008, 28 (04) : 370 - 379
  • [39] Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease
    Sanyal, AJ
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (01): : 46 - 53
  • [40] Mechanisms and disease consequences of nonalcoholic fatty liver disease
    Loomba, Rohit
    Friedman, Scott L.
    Shulman, Gerald, I
    CELL, 2021, 184 (10) : 2537 - 2564
12345